BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 19717847)

  • 41. Usefulness of overlapping of the E and A waves of the transmitral flow as a predictor of responders to cardiac resynchronization therapy.
    Minamiguchi H; Sakata Y; Ohtani T; Mizote I; Takeda Y; Mizuno H; Okuyama Y; Nakatani S; Fujita M; Watanabe T; Uematsu M; Komuro I
    Am J Cardiol; 2013 Jun; 111(11):1613-8. PubMed ID: 23497774
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Cardiac resynchronization therapy (CRT) in patients with still mild heart failure].
    Herz; 2011 Oct; 36(7):643-4. PubMed ID: 22006035
    [No Abstract]   [Full Text] [Related]  

  • 43. Very long term follow-up of cardiac resynchronization therapy: clinical outcome and predictors of mortality.
    Kronborg MB; Mortensen PT; Kirkfeldt RE; Nielsen JC
    Eur J Heart Fail; 2008 Aug; 10(8):796-801. PubMed ID: 18619900
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of cardiac resynchronisation therapy on dilated cardiomyopathy with isolated ventricular non-compaction.
    Bertini M; Ziacchi M; Biffi M; Biagini E; Rocchi G; Martignani C; Ferlito M; Pasquale F; Cervi E; Branzi A; Rapezzi C; Boriani G
    Heart; 2011 Feb; 97(4):295-300. PubMed ID: 21163889
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardiogenic shock shortly after initial success of cardiac resynchronization therapy.
    Kanhai SM; Viergever EP; Bax JJ
    Eur J Heart Fail; 2004 Jun; 6(4):477-81. PubMed ID: 15182774
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stroke work or systolic dP/dtmax to evaluate acute response to cardiac resynchronization therapy: are they interchangeable?
    de Roest G; Knaapen P; Götte M; Hendriks T; Allaart C; de Cock C; van Rossum A
    Eur J Heart Fail; 2009 Jul; 11(7):706-8. PubMed ID: 19553399
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiac resynchronisation as a rescue therapy in patients with catecholamine-dependent overt heart failure: results from a short and mid-term study.
    Milliez P; Thomas O; Haggui A; Schurando P; Squara P; Cohen-Solal A; Mebazaa A; Leenhardt A
    Eur J Heart Fail; 2008 Mar; 10(3):291-7. PubMed ID: 18313982
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heart rates in cardiac resynchronization: the art of optimal device programming.
    Maass AH; van Veldhuisen DJ
    Europace; 2011 Feb; 13(2):157-8. PubMed ID: 21186228
    [No Abstract]   [Full Text] [Related]  

  • 49. Primary results from the SmartDelay determined AV optimization: a comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: a randomized trial comparing empirical, echocardiography-guided, and algorithmic atrioventricular delay programming in cardiac resynchronization therapy.
    Ellenbogen KA; Gold MR; Meyer TE; Fernndez Lozano I; Mittal S; Waggoner AD; Lemke B; Singh JP; Spinale FG; Van Eyk JE; Whitehill J; Weiner S; Bedi M; Rapkin J; Stein KM
    Circulation; 2010 Dec; 122(25):2660-8. PubMed ID: 21098426
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Myocardial collagen metabolism in failing hearts before and during cardiac resynchronization therapy.
    Umar S; Bax JJ; Klok M; van Bommel RJ; Hessel MH; den Adel B; Bleeker GB; Henneman MM; Atsma DE; van der Wall EE; Schalij MJ; van der Laarse A
    Eur J Heart Fail; 2008 Sep; 10(9):878-83. PubMed ID: 18768351
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical and prognostic role of pressure-volume relationship in the identification of responders to cardiac resynchronization therapy.
    Ciampi Q; Pratali L; Citro R; Villari B; Picano E; Sicari R
    Am Heart J; 2010 Nov; 160(5):906-14. PubMed ID: 21095279
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Surface electrocardiogram to predict outcome in candidates for cardiac resynchronization therapy: a sub-analysis of the CARE-HF trial.
    Gervais R; Leclercq C; Shankar A; Jacobs S; Eiskjaer H; Johannessen A; Freemantle N; Cleland JG; Tavazzi L; Daubert C;
    Eur J Heart Fail; 2009 Jul; 11(7):699-705. PubMed ID: 19505883
    [TBL] [Abstract][Full Text] [Related]  

  • 53. QRS width and mechanical dyssynchrony for selection of patients for cardiac resynchronization therapy: one can't do without the other.
    Abraham TP; Olsen NT
    JACC Cardiovasc Imaging; 2010 Feb; 3(2):141-3. PubMed ID: 20159639
    [No Abstract]   [Full Text] [Related]  

  • 54. Selecting patients for cardiac resynchronization therapy: electrical or mechanical dyssynchrony?
    Hawkins NM; Petrie MC; MacDonald MR; Hogg KJ; McMurray JJ
    Eur Heart J; 2006 Jun; 27(11):1270-81. PubMed ID: 16527827
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardiac resynchronization therapy improves exercise heart rate recovery in patients with heart failure.
    Okutucu S; Aytemir K; Evranos B; Aksoy H; Sabanov C; Karakulak UN; Kaya EB; Kabakci G; Tokgozoglu L; Ozkutlu H; Oto A
    Europace; 2011 Apr; 13(4):526-32. PubMed ID: 21076146
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of biventricular pacing on diastolic dyssynchrony.
    Shanks M; Bertini M; Delgado V; Ng AC; Nucifora G; van Bommel RJ; Borleffs CJ; Holman ER; van de Veire NR; Schalij MJ; Bax JJ
    J Am Coll Cardiol; 2010 Nov; 56(19):1567-75. PubMed ID: 21029873
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictors of lack of response to resynchronization therapy.
    Díaz-Infante E; Mont L; Leal J; García-Bolao I; Fernández-Lozano I; Hernández-Madrid A; Pérez-Castellano N; Sitges M; Pavón-Jiménez R; Barba J; Cavero MA; Moya JL; Pérez-Isla L; Brugada J;
    Am J Cardiol; 2005 Jun; 95(12):1436-40. PubMed ID: 15950566
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mechanical synchrony and survival in heart failure.
    Marwick T
    Heart; 2010 Jul; 96(13):999-1000. PubMed ID: 20584854
    [No Abstract]   [Full Text] [Related]  

  • 59. Greater three-dimensional ventricular lead tip separation is associated with improved outcome after cardiac resynchronization therapy.
    Ariga R; Tayebjee MH; Benfield A; Todd M; Lefroy DC
    Pacing Clin Electrophysiol; 2010 Dec; 33(12):1490-6. PubMed ID: 21039639
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiac resynchronization therapy-induced left ventricular reverse remodelling is associated with reduced plasma annexin A5.
    Ravassa S; García-Bolao I; Zudaire A; Macías A; Gavira JJ; Beaumont J; Arias T; Huerta A; Díez J
    Cardiovasc Res; 2010 Nov; 88(2):304-13. PubMed ID: 20542876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.